-
1 week ago | 
spotlightnsp.co.za | Catherine Tomlinson |Siyabonga Kamnqa |Elri Voigt |Biénne Huisman
Health Minister Aaron Motsoaledi. (Photo: Kopano Tlape/GCIS) News & Features17th April 2025 | Jesse Copelyn In late-January, the US suspended billions of dollars worth of international aid, including for HIV-related programmes in South Africa. The South African government could have responded by triggering an emergency funding mechanism but has failed to do so yet.
-
1 month ago | 
spotlightnsp.co.za | Nthusang Lefafa |Tiyese Jeranji |Catherine Tomlinson |Ufrieda Ho
Findings from the BAMMISHO project will inform strategies to address the challenges of mining and migration, fostering sustainable solutions for communities to thrive. (File photo: SAPRIN) News & Features27th February 2025 | Nthusang Lefafa A new health research hub brings hope of improving health services in the Rustenburg Valley in the North West Province.
-
2 months ago | 
spotlightnsp.co.za | Catherine Tomlinson |Marcus Low |Tiyese Jeranji |Andy Gray
#InsideTheBox is a column by Dr Andy Gray, a pharmaceutical sciences expert at the University of KwaZulu-Natal and Co-Director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice.
-
2 months ago | 
spotlightnsp.co.za | Catherine Tomlinson |Tiyese Jeranji |Biénne Huisman |Sue Segar
Nomantu Nkomo-Ralehoko sworn in as MEC for health in Gauteng. (Photo: Gauteng Provincial Government) Comment & Analysis28th January 2025 | Khuselwa Dyantyi The bodily autonomy of young women and girls is under threat as Gauteng Health and Wellness MEC Nomantu Nkomo-Ralehoko intends to make the contraceptive Implanon compulsory for learners as long as their parents consent. This approach to addressing teenage pregnancy is misguided and unlawful, argues Khuselwa Dyantyi.
-
Dec 9, 2024 | 
businesslive.co.za | Catherine Tomlinson
Turning to the private sectorLess well known than Ketlaphela are government’s efforts to support API manufacturing capacity in the private sector. One private company that has received such government support and seems set to start delivering is Pretoria-based Chemical Process Technologies Pharma (CPT Pharma), established in 2014.
-
Dec 4, 2024 | 
dailymaverick.co.za | Catherine Tomlinson
SPOTLIGHT Though several South African companies are producing HIV and TB medicines, the active ingredients that go into these medicines are usually imported from India or China. Now, a local company is planning to break new ground by making the active ingredients for two important TB medicines in Pretoria. South Africa has a relatively robust pharmaceutical sector.
-
Dec 4, 2024 | 
allafrica.com | Catherine Tomlinson
Though several South African companies are producing HIV and TB medicines, the active ingredients that go into these medicines are usually imported from India or China. Now, a local company is planning to break new ground by making the active ingredients for two important TB medicines in Pretoria. We zoom in on the company's efforts and outline some of the obstacles to getting such local production off the ground. South Africa has a relatively robust pharmaceutical sector.
-
Nov 23, 2024 | 
businesslive.co.za | Catherine Tomlinson
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers. The Competition Commission is reviewing two cases about the pricing of cancer medicines. Picture: Unsplash/Etactics Inc The Competition Commission played a pivotal role in South Africa’s historic fight for access to HIV medicines.
-
Nov 20, 2024 | 
brnw.ch | Catherine Tomlinson
There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving cancer medicines seem set to nail down what qualifies as "excessive pricing" in South African law. This legal development could have far-reaching implications for medicines prices in the country. The Competition Commission played a pivotal role in South Africa's historic fight for access to HIV medicines.
-
Nov 20, 2024 | 
allafrica.com | Catherine Tomlinson
There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving cancer medicines seem set to nail down what qualifies as "excessive pricing" in South African law - a legal development that could have far reaching implications for medicines prices in the country. The Competition Commission played a pivotal role in South Africa's historic fight for access to HIV medicines.
